Is fenofibrate a reasonable treatment for diabetic microvascular disease?

Current Diabetes Reports
Rafael SimóCristina Hernández

Abstract

Type 2 diabetes is a pandemic disease, and its prevalence is increasing mainly due to an increase in obesity and life expectancy. Diabetic complications and their comorbidities constitute the most important economic cost of the disease and represent a significant economic burden for the healthcare systems of developed countries. Despite improving standards of care, people with diabetes remain at risk of the development and progression of microvascular diabetic complications. Therefore, the identification of novel therapeutic approaches is necessary. The aim of this article is to provide an overview of the clinical benefits of fenofibrate on microvascular diabetic complications, with special emphasis on diabetic retinopathy. In addition, the potential mechanisms of action will be briefly discussed.

References

Apr 22, 2004·Journal of the American Society of Nephrology : JASN·Lawrence G Hunsicker
Apr 28, 2004·Diabetes Care·Mark E Molitch
Dec 28, 2004·The American Journal of Cardiology·Peter H Jones, Michael H Davidson
Mar 9, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jean-Claude AnsquerUNKNOWN DAIS Investigators
May 5, 2006·Kidney International·C W ParkY Guan
Nov 1, 2006·Biochemical Society Transactions·R BordetM Bastide
Feb 6, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN KDOQI
Nov 9, 2007·Lancet·Rafael Simó, Cristina Hernández
Apr 18, 2008·Current Medical Research and Opinion·Lauren J LeeHoward G Birnbaum
May 27, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jean-Claude AnsquerChristelle Foucher
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Jul 12, 2008·Pharmacology & Therapeutics·James L EdwardsEva L Feldman
Nov 21, 2008·Expert Review of Cardiovascular Therapy·Robert S Rosenson
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
Mar 17, 2010·The New England Journal of Medicine·Henry N GinsbergRobert P Byington
Jun 29, 2010·Lancet·Ning CheungTien Yin Wong
Jul 1, 2010·The New England Journal of Medicine·UNKNOWN ACCORD Study GroupLawrence J Fine
Nov 6, 2010·Diabetologia·T M E DavisUNKNOWN Fenofibrate Intervention and Event Lowering in Diabetes Study investigators
Nov 22, 2011·Expert Review of Pharmacoeconomics & Outcomes Research·Carlo B GiordaJesús Diago Cabezudo
Feb 4, 2012·Diabetes Care·Joanne W Y YauUNKNOWN Meta-Analysis for Eye Disease (META-EYE) Study Group
Aug 14, 2012·The British Journal of Ophthalmology·Rafael SimóUNKNOWN European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)
Feb 23, 2013·PPAR Research·Andreea CiudinRafael Simó
Jun 12, 2013·Current Medicinal Chemistry·Rafael SimóTien Yin Wong
Sep 5, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yang HuJian-xing Ma

❮ Previous
Next ❯

Citations

Jul 31, 2016·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis
Oct 5, 2016·Seminars in Ophthalmology·Hala El RamiPaolo S Silva
Nov 12, 2019·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators
Jan 7, 2017·Journal of Diabetes Research·Luis Miguel Román-PintosErnesto Germán Cardona-Muñoz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Medicina clínica
Rafael Simó, Cristina Hernández
Journal of the American Optometric Association
M D Kirstein
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
Ahmed H Abdelhafiz, Alan J Sinclair
Lancet
Rafael Simó, Cristina Hernández
© 2021 Meta ULC. All rights reserved